Article

Wide-field optical redox imaging with leading-edge detection for assessment of patient-derived cancer organoids

2024-12-23

Abstract excerpt

Patient-derived cancer organoids (PDCOs) are a valuable model to recapitulate human disease in culture with important implications for drug development. However, current methods for assessing PDCOs are limited. Label-free imaging methods are a promising tool to measure organoid level heterogeneity and rapidly screen drug response in PDCOs. The aim of this study was to assess and predict PDCO response to treatments...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 21ee703b-8779-5e72-bc39-7607ea6f5dd1
DOI: 10.1101/2024.12.23.630148

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Wide-field optical redox imaging with leading-edge detection for assessment of patient-derived cancer organoidsDOI 10.1101/2024.12.23.630148Read

Wide-Field Optical Redox Imaging with Leading-Edge Detection Enables Assessment of Treatment Response and Heterogeneity in Patient-Derived Cancer Organoids.Semantic proximity Read

An automated image analysis pipeline for wide-field optical redox imaging of patient-derived cancer organoidsSemantic proximity Read

“Proteotranscriptomic analysis of advanced colorectal cancer patient derived organoids for drug sensitivity prediction”Semantic proximity Read

Using Genetically Encoded Fluorescent Biosensors to Interrogate Ovarian Cancer MetabolismSemantic proximity Read

Optical Metabolic Imaging of Heterogeneous Drug Response in Pancreatic Cancer Patient OrganoidsSemantic proximity Read

Colorectal cancer organoid models uncover oxaliplatin-resistant mechanisms at single cell resolutionSemantic proximity Read

Quantitative Spatial Analysis of Metabolic Heterogeneity Across in vivo and in vitro Tumor ModelsSemantic proximity Read

Multiplexed live-cell imaging for drug responses in patient-derived organoid models of cancerSemantic proximity Read

Unveiling radiobiological traits and therapeutic responses of BRAFV600E-mutant colorectal cancer via patient-derived organoidsSemantic proximity Read

Insights into metabolic heterogeneity of colorectal cancer gained from fluorescence lifetime imagingSemantic proximity Read

Organoids as a biomarker for personalized treatment in metastatic colorectal cancer: drug screen optimization and correlation with patient responseSemantic proximity Read

Porphyrin overdrive rewires pan-cancer cell metabolismSemantic proximity Read